Inspire Medical Systems Inc expected to post a loss of 10 cents a share - Earnings Preview

Inspire Medical Systems

02/02/2024 23:05

* Inspire Medical Systems Inc  INSP.N   INSP.K  is expected
to show a rise in quarterly revenue when it reports  results on
February 6 for the period ending December 31 2023
    * The Golden Valley Minnesota-based  company is expected to
report
a 35.5% increase in revenue to $186.894 million from $137.9
million a year ago, according to the mean estimate from 15
analysts, based on LSEG data.The company's guidance on January 8
2024, for the period ended December 31, was for revenue between
$192.30 million and $192.50 million.
    * ​LSEG's mean analyst estimate for Inspire Medical Systems
Inc is
for a loss of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inspire
Medical
Systems Inc is $240.00​, above​ its last closing price
of $218.03. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.53       -0.58      -0.29     Beat    50
 Jun. 30 2023  -0.54       -0.57      -0.41     Beat    28
 Mar. 31 2023  -0.67       -0.66      -0.53     Beat    19.7​
 Dec. 31 2022  -0.48       -0.57      0.10      Beat    117.7
 ​​Sep.        -0.74       -0.77      -0.60     Beat    21.7
 30 2022                                                
 Jun. 30 2022  -0.61       -0.62      -0.53     Beat    14.3​
 Mar. 31 2022  -0.75       -0.80      -0.61     Beat    23.4
 Dec. 31 2021  -0.41       -0.44      -0.09     Beat    79.4
 This summary was machine generated February 2 at 23:05 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)